Projet Paladin en Chine: Traitement pour le cancer du foie
Overview
As China joins the World Trade Organization (WTO), it will need to integrate more completely into the global economy. The international competition will place an intense pressure on the Chinese pharmaceutical industry. Accession to the WTO will bind China by fundamental WTO principles, such as improved transparency and the strengthening of commercial legal procedures. China's WTO commitments include the tightening of rules on intellectual property, tariff concessions, and market access of non-Chinese service suppliers engaging in the distribution of pharmaceuticals. (Cheri Grace; 2004)
Investment conditions in China have improved due to the vast consumer demand for pharmaceuticals, the lower labor costs and the changes resulting from economic reform. Changes to the patenting laws in full compliance with the requirement of the Agreement on Trade-Related Aspects of Intellectual Property Rights (or "TRIPS Agreement") and the lack of Chinese pharmaceutical R&D have also left gaps in the market.
The domestic pharmaceutical industry has been a key contributor to the country’s impressive economic growth. As one of the world's major producers of pharmaceuticals, the sector achieved an annual compound growth rate of 16.7% between 1978 and 2003. Both far outpaced other economies in the world, making China the world's fastest growing pharmaceutical market. Although China has enjoyed the benefits of an expansive market for pharmaceutical production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector's economies of scale have yet to be achieved. Most domestic manufacturers in the pharmaceutical industry lack the autonomic intellectual property and financial resources to develop their own brand name products. Most manufacturers rely on the repetitive production of low value added bulk pharmaceuticals and imitation drugs.[3]
As China joins the World Trade Organization (WTO), it will need to integrate more completely into the global economy. The international competition will place an intense pressure on the Chinese pharmaceutical industry. Accession to the WTO will bind China by fundamental WTO principles, such as improved transparency and the strengthening of commercial legal procedures. China's WTO commitments include the tightening of rules on intellectual property, tariff concessions, and market access of non-Chinese service suppliers engaging in the distribution of pharmaceuticals. (Cheri Grace; 2004)
Investment conditions in China have improved due to the vast consumer demand for pharmaceuticals, the lower labor costs and the changes resulting from economic reform. Changes to the patenting laws in full compliance with the requirement of the Agreement on Trade-Related Aspects of Intellectual Property Rights (or "TRIPS Agreement") and the lack of Chinese pharmaceutical R&D have also left gaps in the market.
The domestic pharmaceutical industry has been a key contributor to the country’s impressive economic growth. As one of the world's major producers of pharmaceuticals, the sector achieved an annual compound growth rate of 16.7% between 1978 and 2003. Both far outpaced other economies in the world, making China the world's fastest growing pharmaceutical market. Although China has enjoyed the benefits of an expansive market for pharmaceutical production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector's economies of scale have yet to be achieved. Most domestic manufacturers in the pharmaceutical industry lack the autonomic intellectual property and financial resources to develop their own brand name products. Most manufacturers rely on the repetitive production of low value added bulk pharmaceuticals and imitation drugs.[3]
http://209.85.133.132/translate_c?hl=fr&sl=en&u=http://www.china.org.cn/e-company/index.htm&prev=/search%3Fq%3DChinese%2BEmbassy%2Bin%2BCanada%26hl%3Dfr%26rlz%3D1G1GGLQ_FRCA282%26sa%3DX&usg=ALkJrhjOzkM4glCZUt8wbfeebSaEo0KxbA
Version traduite de la page http://www.china.org.cn/e-company/index.htm
http://fr.wikipedia.org/wiki/Censure_en_R%C3%A9publique_populaire_de_Chine
Censure en République populaire de Chine - Wikipédia
http://http://www.most.gov.cn/eng/statistics/2007/200801/P020080109573867344872.pdf
http://www.most.gov.cn/eng/statistics/2007/200801/P020080109573867344872.pdf
Montrer
Motorisé par 
netvibes
netvibes